Abstract
Atrial septal defect is one of the most frequent congenital heart defects. With the development of cardiac surgery the closure of atrial septal defects is increasingly performed by the endovascular approach. One of the rare but most serious complications after occluder implantation is the development of erosion. The article presents a case of an erosive complication after endovascular closure of atrial septal defect in a years old child developed on the third day after occluder implantation complicated by cardiac tamponade.
References
- Hoffman J.I.E, Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002; 39: 1890–900. DOI: 10.1016/s0735-1097(02)01886-7
- Ooi Y.K., Kelleman M., Ehrlich A., Glanville M., Porter A., Kim D. et al. Transcatheter versus surgical closure of atrial septal defects in children: a value comparison. JACC Cardiovasc. Interv. 2016; 9 (1): 79–86. DOI: 10.1016/j.jcin.2015.09.028
- Butera G., Carminati M., Chessa M., Youssef R., Drago M., Giamberti A. et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am. Heart J. 2006; 151 (1): 228–34. DOI: 10.1016/j.ahj.2005.02.051
- Turner D.R., Owada C.Y., Sang C.J., Khan M., Lim D.S. Closure of secundum atrial septal defects with the AMPLATZER septal occluder: a prospective, multicenter, Post-Approval Study. Circ. Cardiovasc. Interv. 2017; 10 (8): 1–7. DOI: 10.1161/CIRCINTERVENTIONS.116.004212
- Amin Z., Hijazi Z.M., Bass J.L., Cheatham J.P., Hellenbrand W.E., Kleinman C.S. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter. Cardiovasc. Interv. 2004; 63 (4): 496–502. DOI: 10.1002/ccd.2021
- Di Bardino D.J., McElhinney D.B., Kaza A.K., Mayer J.E. Jr. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery Congenital Cardiac Surgery database. J. Thorac. Cardiovasc. Surg. 2009; 137: 1334–41. DOI: 10.1016/j.jtcvs.2009.02.032
- Will T. Roberts, Jitendra Parmar, Thirumaran Rajathurai. Very late erosion of Amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement. Catheter. Cardiovasc. Interv. 2013; 82 (4): E592–4. DOI: 10.1002/ccd.24755
- Rare and Serious Erosion Events Associated with St. Jude Amplatzer Atrial Septal Occluder (ASO). United States Food and Drug Administration; 2013. Available at: https://www. medicaldesignandoutsourcing.com (accessed December 06, 2021).
-
- Alekyan B.G., Sobolev A.V., Pursanov M.G. Endovascular closure of atrial septal defects with the Amplatz occluder. In: Endovascular surgery: The National Guideline. By ed. B.G. Alekyan. Vol. 1. Congenital Heart Diseases. Moscow: Litterra; 2017: 341–61 (in Russ.).
- Abe T., Tsukano S., Tosaka Y. Pericardial tamponade due to erosion of a Figulla Flex II deviceafter closure of an atrial septal defect. Catheter. Cardiovasc. Interv. 2019; 94 (7): 1003–5. DOI: 10.1002/ccd.28367
- O’Byrne M.L., Glatz A.C., Sunderji S., Mathew A.E., Goldberg D.J., Dori Y. et al. Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects. Pediatr. Cardiol. 2014; 35: 1181–90. DOI: 10.1007/s00246-014-0914-6
- O’Byrne M.L., Gillespie M.J., Kennedy K.F., Dori Y., Rome J.J., Glatz A.C. The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: an analysis of the IMPACT Registry. Catheter. Cardiovasc. Interv. 2017; 89: 102–11. DOI: 10.1002/ccd.26585
- O’Byrne M.L., Glatz A.C., Goldberg D.J., Shinohara R., Dori Y., Rome J.J., Gillespie M.J. Accuracy of transthoracic echocardiography in assessing retro-aortic rim prior to device closure of atrial septal defects. Congenit. Heart Dis. 2015; 10 (4): E146–54. DOI: 10.1111/chd.12226
About the authors
- Manolis G. Pursanov, Dr. Med. Sci., Professor, Endovascular Surgeon; ORCID
- Mikhail A. Abramyan, Dr. Med. Sci., Professor, Head of Department; ORCID
- Yuriy N. Shamrin, Dr. Med. Sci., Cardiovascular Surgeon; ORCID
- Alexey V. Bedin, Cardiovascular Surgeon; ORCID
- Davronbek B. Pardaev, Endovascular Surgeon; ORCID
- Vladimir P. Miroshnichenko, Pediatric Cardiologist; ORCID
- Maria M. Kurako, Cand. Med. Sci., Doctor of Functional and Ultrasound Diagnostics; ORCID
